Urological Applications of Botulinum Toxin
作者： Courtenay K. Moore , Howard B. Goldman
DOI: 10.1007/978-1-59745-368-4_14
关键词:
摘要: Botulinum toxin is a neurotoxin produced by the Gram-positive, rod-shaped anaerobic bacterium Clostridium botulinum (1). First discovered in 1897 Professor Pierre Emile van Ermengem of Ellezelles, Belgium most poisonous naturally occurring known to man (2). Seven immunologically distinct antigenic subtypes have been isolated: A, B, C1, D, E, F, and G Only types A B are available for use clinically. type (BTX-A), as Botox® United States Dysport® Kingdom, more potent has longer duration action than (1,2). Type commercially MyoBloc® Europe NeuroBloc®
springer.com
sci-hub.st 参考文章(25)
Dennis D. Dykstra, Abraham A. Sidi, Alan B. Scott, Julie M. Pagel, Gary D. Goldish, Effects of Botulinum a Toxin on Detrusor-Sphincter Dyssynergia in Spinal Cord Injury Patients The Journal of Urology. ,vol. 139, pp. 919- 922 ,(1988) , 10.1016/S0022-5347(17)42717-0
David E. Rapp, Alvaro Lucioni, Erin E. Katz, R.Corey O'Connor, Glenn S. Gerber, Gregory T. Bales, Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience Urology. ,vol. 63, pp. 1071- 1075 ,(2004) , 10.1016/J.UROLOGY.2004.01.041
Govindaraj N. Rajkumar, Douglas R. Small, Abdul W. Mustafa, Graeme Conn, A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJUI. ,vol. 96, pp. 848- 852 ,(2005) , 10.1111/J.1464-410X.2005.05725.X
Christopher P. Smith, Vijaya M. Vemulakonda, Susanna Kiss, Timothy B. Boone, George T. Somogyi, Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: Effect of botulinum toxin A Neurochemistry International. ,vol. 47, pp. 291- 297 ,(2005) , 10.1016/J.NEUINT.2005.04.021
HANN-CHORNG KUO, Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. The Journal of Urology. ,vol. 170, pp. 1908- 1912 ,(2003) , 10.1097/01.JU.0000091281.50081.F0
Christopher P. Smith, Piotr Radziszewski, Andrzej Borkowski, George T. Somogyi, Timothy B. Boone, Michael B. Chancellor, Botulinum toxin a has antinociceptive effects in treating interstitial cystitis Urology. ,vol. 64, pp. 871- 875 ,(2004) , 10.1016/J.UROLOGY.2004.06.073
Roshni Popat, Apostolos Apostolidis, Vinay Kalsi, Gwendoline Gonzales, Clare J Fowler, Prokar Dasgupta, None, A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. The Journal of Urology. ,vol. 174, pp. 984- 989 ,(2005) , 10.1097/01.JU.0000169480.43557.31
Marcus Riccabona, Mark Koen, Monica Schindler, Beckers Goedele, Armin Pycha, Lukas Lusuardi, BOTULINUM-A TOXIN INJECTION INTO THE DETRUSOR: A SAFE ALTERNATIVE IN THE TREATMENT OF CHILDREN WITH MYELOMENINGOCELE WITH DETRUSOR HYPERREFLEXIA The Journal of Urology. ,vol. 171, pp. 845- 848 ,(2004) , 10.1097/01.JU.0000108892.35041.2D
Joachim Grosse, Guus Kramer, Manfred Stöhrer, Success of Repeat Detrusor Injections of Botulinum A Toxin in Patients with Severe Neurogenic Detrusor Overactivity and Incontinence European Urology. ,vol. 47, pp. 653- 659 ,(2003) , 10.1016/J.EURURO.2004.11.009
H. Schulte-Baukloh, Th. Michael, B. Stürzebecher, H.H. Knispel, Botulinum-A Toxin Detrusor Injection as a Novel Approach in the Treatment of Bladder Spasticity in Children with Neurogenic Bladder European Urology. ,vol. 44, pp. 139- 143 ,(2003) , 10.1016/S0302-2838(03)00136-2